1-207752250-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_172351.3(CD46):​c.38C>T​(p.Ser13Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00207 in 1,614,152 control chromosomes in the GnomAD database, including 59 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0031 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 55 hom. )

Consequence

CD46
NM_172351.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.449
Variant links:
Genes affected
CD46 (HGNC:6953): (CD46 molecule) The protein encoded by this gene is a type I membrane protein and is a regulatory part of the complement system. The encoded protein has cofactor activity for inactivation of complement components C3b and C4b by serum factor I, which protects the host cell from damage by complement. In addition, the encoded protein can act as a receptor for the Edmonston strain of measles virus, human herpesvirus-6, and type IV pili of pathogenic Neisseria. Finally, the protein encoded by this gene may be involved in the fusion of the spermatozoa with the oocyte during fertilization. Mutations at this locus have been associated with susceptibility to hemolytic uremic syndrome. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jun 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003166467).
BP6
Variant 1-207752250-C-T is Benign according to our data. Variant chr1-207752250-C-T is described in ClinVar as [Benign]. Clinvar id is 875708.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-207752250-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00305 (465/152372) while in subpopulation EAS AF= 0.0359 (186/5180). AF 95% confidence interval is 0.0317. There are 4 homozygotes in gnomad4. There are 248 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CD46NM_172351.3 linkuse as main transcriptc.38C>T p.Ser13Phe missense_variant 1/13 ENST00000367042.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CD46ENST00000367042.6 linkuse as main transcriptc.38C>T p.Ser13Phe missense_variant 1/131 NM_172351.3 A2P15529-11

Frequencies

GnomAD3 genomes
AF:
0.00303
AC:
462
AN:
152254
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00383
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00425
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0356
Gnomad SAS
AF:
0.00538
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.00510
AC:
1282
AN:
251418
Hom.:
21
AF XY:
0.00418
AC XY:
568
AN XY:
135900
show subpopulations
Gnomad AFR exome
AF:
0.00369
Gnomad AMR exome
AF:
0.0148
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0321
Gnomad SAS exome
AF:
0.00261
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000237
Gnomad OTH exome
AF:
0.00195
GnomAD4 exome
AF:
0.00197
AC:
2883
AN:
1461780
Hom.:
55
Cov.:
31
AF XY:
0.00188
AC XY:
1366
AN XY:
727210
show subpopulations
Gnomad4 AFR exome
AF:
0.00341
Gnomad4 AMR exome
AF:
0.0138
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0384
Gnomad4 SAS exome
AF:
0.00248
Gnomad4 FIN exome
AF:
0.0000562
Gnomad4 NFE exome
AF:
0.000232
Gnomad4 OTH exome
AF:
0.00247
GnomAD4 genome
AF:
0.00305
AC:
465
AN:
152372
Hom.:
4
Cov.:
32
AF XY:
0.00333
AC XY:
248
AN XY:
74506
show subpopulations
Gnomad4 AFR
AF:
0.00385
Gnomad4 AMR
AF:
0.00431
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.0359
Gnomad4 SAS
AF:
0.00539
Gnomad4 FIN
AF:
0.000282
Gnomad4 NFE
AF:
0.000265
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.00115
Hom.:
2
Bravo
AF:
0.00405
ESP6500AA
AF:
0.00409
AC:
18
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00500
AC:
607
Asia WGS
AF:
0.0170
AC:
60
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000237

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:1
Benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of ChicagoSep 02, 2022- -
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
CD46-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesOct 31, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Atypical hemolytic-uremic syndrome Benign:1
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenFeb 25, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
2.6
DANN
Benign
0.77
DEOGEN2
Benign
0.17
T;.;.;.;.;.;.;.;.;.
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.18
N
LIST_S2
Uncertain
0.87
D;D;T;D;T;T;D;T;T;D
MetaRNN
Benign
0.0032
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.6
L;L;L;L;L;L;L;L;L;L
MutationTaster
Benign
1.0
N;N;N;N;N;N;N;N;N;N;N;N
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.6
N;N;N;N;N;N;N;N;N;N
REVEL
Benign
0.094
Sift
Benign
0.14
T;T;T;T;T;T;T;D;T;T
Sift4G
Benign
0.18
T;T;T;T;T;T;T;D;T;T
Polyphen
1.0
D;B;B;B;D;B;B;.;B;D
Vest4
0.065
MVP
0.46
MPC
0.23
ClinPred
0.0050
T
GERP RS
-0.72
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.2
Varity_R
0.044
gMVP
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138843816; hg19: chr1-207925595; COSMIC: COSV59736141; API